COMPLICATIONS DIGESTIVES et CEC
08-10/2007
(1) Shen Z, Wang Z, Zhang J, Jing H:
Hepatic injury in a rat cardiopulmonary bypass model.
Interact.Cardiovasc.Thorac.Surg. 2007; %19;.:
(2) Huang H, Yin R, Zhu J, Feng X, Wang C, Sheng Y, Dong G, Li
D, Jing H: Protective effects of melatonin and N-acetylcysteine
on hepatic injury in a rat cardiopulmonary bypass model. J.Surg.Res.
2007; 142: 153-61
(3) Fondevila C, Hessheimer AJ, Ruiz A, Calatayud D, Ferrer J,
Charco R, Fuster J, Navasa M, Rimola A, Taura P, Gines P, Manyalich M, Garcia-Valdecasas
JC: Liver transplant using donors after unexpected cardiac
death: novel preservation protocol and acceptance criteria.
Am.J.Transplant. 2007; 7: 1849-55
(4) Filsoufi F, Salzberg SP, Rahmanian PB, Schiano TD, Elsiesy
H, Squire A, Adams DH: Early and late outcome of cardiac
surgery in patients with liver cirrhosis. Liver Transpl. 2007; 13: 990-5
(5) Filsoufi F, Rahmanian PB, Castillo JG, Scurlock C, Legnani
PE, Adams DH: Predictors and outcome of gastrointestinal
complications in patients undergoing cardiac surgery. Ann.Surg. 2007;
246: 323-9
(6) An Y, Xiao YB: Growth hormone prevents
acute liver injury induced by cardiopulmonary bypass in a rat model.
J.Thorac.Cardiovasc.Surg. 2007; 134: 342-50
07/2007
(1) Yu J, Xiao YB, Wang XY:
Effects of preoperatively selected gut decontamination on cardiopulmonary bypassjinduced endotoxemia.
Chin J.Traumatol. 2007; 10: 131-7
(2) Kurobe H, Kitaichi T, Shimahara Y, Kanemura T, Kanbara T, Kurushima A, Kano M, Hori T, Yoshida H, Urata M, Kitagawa T:
Significance of peritoneal fluid drainage in management after repair of complex heart defects in infancy: cytokine dynamics in vivo.
Circ.J. 2007; 71: 941-7
(3) An Y, Xiao YB:
The preventative role of growth hormone on acute liver injury induced by cardiopulmonary bypass in a rat model.
Eur .J.Cardiothorac.Surg. 2007; 31: 1037-43
(4) Huybregts RA, Morariu AM, Rakhorst G, Spiegelenberg SR, Romijn HW, de Vroege R, van Oeveren W:
Attenuated renal and intestinal injury after use of a mini-cardiopulmonary bypass system.
Ann.Thorac.Surg. 2007; 83: 1760-6
(5) Nys M, Venneman I, Deby-Dupont G, Preiser JC, Vanbelle S, Albert A, Camus G, Damas P, Larbuisson R, Lamy M:
Pancreatic cellular injury after cardiac surgery with cardiopulmonary bypass: frequency, time course and risk factors. Shock. 2007; 27: 474-81
05/2007
(1) Braun JP, Buhner S, Kastrup M, Dietz E, Langer K, Dohmen PM et al. Barrier function of the gut and multiple organ dysfunction after cardiac surgery. J Int Med Res 2007; 35(1):72-83.
01/2007
(1) Heying R, van Oeveren W, Wilhelm S,
Schumacher K, Grabitz RG, Messmer BJ, Seghaye MC: Children undergoing cardiac
surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic
activity. Crit Care. 2006; 10: R165
09/2006
(1) Fiore G, Brienza N, Cicala P,
Tunzi P, Marraudino N, Schinosa LL et al. Superior mesenteric
artery blood flow modifications during off-pump coronary surgery. Ann
Thorac Surg 2006; 82(1):62-67.
04/2006
(2) Khan JH, Lambert AM, Habib JH, Broce M, Emmett MS, Davis EA: Abdominal
complications after heart surgery. Ann.Thorac.Surg. 2006; 82: 1796-801
(3) Heninger C, Ramamoorthy C, Amir G, Kamra K, Reddy VM, Hanley FL, Brock-Utne
JG: Esophageal saturation during antegrade cerebral perfusion: a preliminary
report using visible light spectroscopy. Paediatr.Anaesth. 2006; 16: 1133-7
(4) Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG: Effects of
sevoflurane on biomechanical markers of hepatic and renal dysfunction after
coronary artery surgery. J.Cardiothorac.Vasc.Anesth. 2006; 20: 684-90
(5) McMonagle MP, Halpenny M, McCarthy A, Mortell A, Manning F, Kilty C, Mannion
D, Wood AE, Corbally MT: Alpha glutathione S-transferase: a potential marker of
ischemia-reperfusion injury of the intestine after cardiac surgery?
J.Pediatr.Surg. 2006; 41: 1526-31
(2) Gu YJ, de Kroon TL, Elstrodt JM, Rakhorst G.
Gastrointestinal motility during cardiopulmonary bypass: a sonomicrometric study.
Artif Organs 2006; 30(7):548-553.
(3) Holland A, Thuemer O, Schelenz C, van Hout N, Sakka SG.
Positive end-expiratory pressure does not affect indocyanine
green plasma disappearance rate or gastric mucosal perfusion after cardiac
surgery. Eur J Anaesthesiol 2006; :1-7.:1-7.
(4) Nygren A, Thoren A, Houltz E, Ricksten SE.
Autoregulation of human jejunal mucosal perfusion during cardiopulmonary bypass.
Anesth Analg 2006; 102(6):1617-1622.
(1) Ascione R, Talpahewa S,
Rajakaruna C, Reeves BC, Lovell AT, Cohen A et al. Splanchnic
organ injury during coronary surgery with or without cardiopulmonary bypass: a
randomized, controlled trial. Ann Thorac Surg 2006; 81(1):97-103.
(2) Braun JP, Schroeder T, Buehner S, Jain U, Dopfmer U, Schuster J et
al. Small-dose epoprostenol decreases systemic oxygen
consumption and splanchnic oxygen extraction during normothermic cardiopulmonary
bypass. Anesth Analg 2006; 102(1):17-24.
01/2006
(1) Wolff T,
Baykut D, Zerkowski HR, Stierli P, Gurke L. Combined abdominal aortic aneurysm
repair and coronary artery bypass: presentation of 13 cases and review of the
literature. Ann Vasc Surg 2006; 20(1):23-29.
(2) Braun JP, Schroeder T, Buehner S, Jain U, Dopfmer U, Schuster J et
al. Small-dose epoprostenol decreases systemic oxygen consumption and splanchnic
oxygen extraction during normothermic cardiopulmonary bypass. Anesth Analg 2006;
102(1):17-24.
(3) Ascione R, Talpahewa S, Rajakaruna C, Reeves BC, Lovell AT, Cohen A
et al. Splanchnic organ injury during coronary surgery with or without
cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg 2006;
81(1):97-103.
(4) Carricart M, Denault AY, Couture P, Limoges P, Babin D, Levesque S et
al. Incidence and significance of abnormal hepatic venous Doppler flow
velocities before cardiac surgery. J Cardiothorac Vasc Anesth 2005;
19(6):751-758.
(5) Onorati F, Cristodoro L, Mastroroberto P, di Virgilio A, Esposito A,
Bilotta M et al. Should we discontinue intraaortic balloon during cardioplegic
arrest? Splanchnic function results of a prospective randomized trial. Ann
Thorac Surg 2005; 80(6):2221-2228.
(6) Bolcal C, Iyem H, Sargin M, Mataraci I, Sahin MA, Temizkan V et al.
Gastrointestinal complications after cardiopulmonary bypass: sixteen years of
experience. Can J Gastroenterol 2005; 19(10):613-617.
(7) But AK, Durmus M, Toprak HI, Ozturk E, Demirbilek S, Ersoy MO.
Hemodynamic, hepatorenal, and postoperative effects of desflurane-fentanyl and
midazolam-fentanyl anesthesia in coronary artery bypass surgery. J Cardiothorac
Vasc Anesth 2005; 19(5):597-602.
(8) Perner A, Jorgensen VL, Poulsen TD, Steinbruchel D, Larsen B,
Andersen LW. Increased concentrations of L-lactate in the rectal lumen in
patients undergoing cardiopulmonary bypass. Br J Anaesth 2005; 95(6):764-768.
03/2005
(1) Andersson B, Nilsson J, Brandt J,
Hoglund P, Andersson R. Gastrointestinal complications after cardiac surgery.
Br J Surg 2005; .
(2) Andrasi TB, Blazovics A, Szabo G, Vahl CF, Hagl S. Poly(ADP-ribose)
polymerase inhibitor PJ-34 reduces the mesenteric vascular injury induced by
experimental cardiopulmonary bypass with cardiac arrest. Am J Physiol Heart
Circ Physiol 2005; .
(3) Omoto T, Kamiya K, Akita S, Sugiyama K, Kume M, Kashima T et al.
Nonocclusive mesenteric ischemia after cardiopulmonary bypass. J Artif
Organs 2004; 7(3):161-163.
(4) Szabo G, Soos P, Mandera S, Heger U, Flechtenmacher C, Seres L et al.
Mesenteric injury after cardiopulmonary bypass: role of poly(adenosine 5'-diphosphate-ribose)polymerase.
Crit Care Med 2004; 32(12):2392-2397.